AI assistant
Barinthus Biotherapeutics plc. — Director's Dealing 2021
Apr 30, 2021
34488_dirs_2021-04-29_eedbc77f-0666-498a-937f-f79ace4b3927.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vaccitech plc (VACC)
CIK: 0001828185
Period of Report: 2021-04-29
Reporting Person: Wright Robin (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 10506 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Share Option (Right to Buy) | $0.0001 | 2030-01-07 | Ordinary Shares (20394) | Direct |
Footnotes
F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2: Represents underlying unexercised share options that were granted on January 7, 2020. The terms of the original grant provide that one-third of this option shall vest and become exercisable on each of January 7, 2020, August 3, 2020 and August 3, 2021. The exercise price of this option is GBP 0.000032 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3662 to GBP 1.00 on December 31, 2020.